Cargando…
Discovering the potential active ingredients of Qi-Yu-San-Long decoction for anti-oxidation, inhibition of non-small cell lung cancer based on the spectrum-effect relationship combined with chemometric methods
Qi-Yu-San-Long decoction (QYSLD), a traditional Chinese medicine (TCM) prescription, consisting of ten types of herbal medicine which has significant clinical efficacy in the treatment of non-small cell lung cancer (NSCLC). However, the bioactive ingredients of QYSLD remain unclear, due to their “mu...
Autores principales: | Huang, Mengwen, Li, Ruijuan, Yang, Mo, Zhou, An, Wu, Hong, Li, Zegeng, Wu, Huan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627220/ https://www.ncbi.nlm.nih.gov/pubmed/36339563 http://dx.doi.org/10.3389/fphar.2022.989139 |
Ejemplares similares
-
The dynamic metabolic profile of Qi-Yu-San-Long decoction in rat urine using UPLC-QTOF-MS(E) coupled with a post-targeted screening strategy
por: Zheng, Ting, et al.
Publicado: (2022) -
Study on the liver Drug’s dominant metabolic enzymes for six effective components of the Huang qi Liuyi decoction
por: Wang, Qun, et al.
Publicado: (2023) -
The Mechanisms of Yu Ping Feng San in Tracking the Cisplatin-Resistance by Regulating ATP-Binding Cassette Transporter and Glutathione S-Transferase in Lung Cancer Cells
por: Du, Yingqing, et al.
Publicado: (2021) -
Metabolic Insight Into the Neuroprotective Effect of Tao-He-Cheng-Qi (THCQ) Decoction on ICH Rats Using Untargeted Metabolomics
por: Yang, Rui-Pei, et al.
Publicado: (2021) -
Jia-Wei-Yu-Ping-Feng-San Attenuates Group 2 Innate Lymphoid Cell-Mediated Airway Inflammation in Allergic Asthma
por: Xue, Lingna, et al.
Publicado: (2021)